Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
9 YR |
Sex |
Female |
Racial Category |
White |
|
Data Elements |
Clinical Element Type: Propionic Acidemia |
(Baseline) |
Neonatal Data |
Was this child newborn screened? |
yes no unknown |
If yes, was the result prior to hospitalization |
No Data |
Weight at birth in kgs |
3.49 |
Length at birth in cm |
53.34 |
Was child breast-fed? |
yes no unknown |
If yes, duration in months |
2 DAYS |
Failure to thrive? |
yes no unknown |
Molecular/Enzyme Laboratory Test Results |
Which Gene: PCCA? |
yes no unknown |
Which Gene: PCCB? |
yes no unknown |
Mutations Allele 1 |
418DELC |
Mutations Allele 2 |
1593_1595DELATT |
Method (if known) |
No Data |
Enzyme activity - % of normal |
0 |
Absolute amount |
No Data |
Family History |
Are there other family members with PA? |
yes no unknown |
Number of siblings with PA |
No Data |
Number of living siblings with PA |
No Data |
Other affected relatives? |
yes no unknown |
If so, Relationship |
No Data |
Has the individual passed away? |
yes no unknown |
If yes, age at death |
No Data |
Clinical Evaluation |
Current weight in kgs |
24.49 |
Current height in cms |
121.92 |
Respiratory |
Apnea |
yes no unknown |
Tachypnea |
yes no unknown |
Cardiovascular |
Cardiomyopathy |
yes no unknown |
If yes, type |
No Data |
Age at diagnosis of cardiomyopathy |
No Data |
Age at time of transplant |
No Data |
Long QT? |
yes no unknown |
If yes, type |
No Data |
Age at diagnosis of long QT |
No Data |
Abdominal/Gastrointestinal |
Pancreatitis |
chronic acute never noted |
Kidney problems |
yes no unknown |
Liver transplant |
yes no unknown |
If yes, age at transplant |
No Data |
Port-a-cath |
currently in place not currently in place never had one |
Gut motility |
normal slow requires medication unknown |
List medications |
No Data |
Reflux |
yes no unknown |
List medications |
No Data |
Eating by mouth |
0% |
Tube fed |
yes no unknown |
If yes, what kind |
G-tube |
Vomiting |
infrequently |
Are anti-emetics used for vomiting |
yes no unknown |
List medications |
No Data |
Neurologic |
Basal ganglia damage |
yes no unknown |
If yes, determined by |
MRI CT Other unknown |
Seizures |
yes no unknown |
If yes, type and frequency |
No Data |
Autism spectrum disorder |
yes no unknown |
ADD/ADHD |
yes no unknown |
Optic nerve damage |
yes no unknown |
If yes, age at detection |
No Data |
Neutropenia |
chronic acute unknown |
List medications |
No Data |
Anemia |
yes no unknown |
If yes, type of anemia |
No Data |
Immune deficiency |
yes no unknown |
Treated with IVIG |
yes no unknown |
Low platelets |
chronic acute not applicable unknown |
Asthma |
yes no unknown |
Secondary hip dysplasia |
yes no unknown |
Broken bones |
yes no unknown |
If yes, type of fracture and location |
ARM |
Short stature |
yes no unknown |
Growth hormone treatment |
yes no unknown |
Osteoporosis |
yes no unknown |
Developmental Evaluation |
Walking |
100% of the time |
Age when first walked |
2 YEARS |
Language |
significantly below age level |
Age when first talked |
3.5 YEARS |
Congitive ability |
moderately impaired |
IQ |
known untested unsure |
If known, give value or age level |
No Data |
Metabolic |
Is the individual biotin responsive |
yes no unknown |
Episodes of ketoacidosis |
yes no unknown |
If yes, give frequency |
once a week or more |
Chronic hyperammonemia |
yes no unknown |
Currently elevated |
<2 times normal |
Is the individual currently on metabolic formula |
yes no unknown |
If yes, which ones |
Propimex SHS XMTVI OA Pro-phree PFD 80056 Duocal Polcyose Vitaflo
|
Is the individual taking levocarnitine |
yes no unknown |
If yes, mg/kg |
No Data |
Other supllements |
Co-Q10 DHA Vitamin E B-6 Biotin Thiamin Multi-vitamin Iron Other None Unknown
|
Remarks |
Clinically affected; no family history; failure to thrive; acute pancreatitis; port-a-cath in place; normal gut motility; fed by G-tube; infrequent vomiting; basal ganglia damage; acute neutropenia; acute anemia; immunodeficiency treated with IVIG; acutely low platelets; broken arm; short stature; began walking at 2 years of age; began talking at 3.5 years of age; language significantly below age level; cognitive ability moderately impaired; episodes of ketoacidosis once a week or more; chronic hyperammonemia <2 times normal; currently on metabolic formula; donor subject is a compound heterozygote: one allele has a 1 bp deletion at nucleotide 418 of the PCCA gene (c.418delC) resulting in a frameshift (H140fs) and the second allele has a 3 bp deletion at nucleotide 1593 in exon 18 (1593_1595delATT) resulting in a frameshift and stop at codon Leu532 |